I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

The research on use of lasers in dentistry dates back as early as 1960s, but it was only in 1985 that the first documented use of a laser in periodontal surgery was published.\[[@ref1]\]

Wigdor *et al*.,\[[@ref2]\] described the advantages of lasers over cold steel surgical procedures as follows:

Dry and bloodless surgeryMinimal postoperative swelling and scarringReduces bacteremiaInstant sterilization of the surgical siteReduced mechanical traumaMinimal postoperative pain.

Studies on healing period of laser wounds compared to scalpel wounds have been rather inconclusive: Some suggest a faster healing rate,\[[@ref3][@ref4][@ref5]\] some suggest slower\[[@ref6][@ref7][@ref8][@ref9][@ref10]\] while some others report no significant difference.\[[@ref11][@ref12]\]

The mechanism behind laser hemostasis has been suggested to be increased platelet activation at the point of wound causing sealing of blood vessels.\[[@ref13]\] Because lasers provide excellent hemostasis, the need for suturing is significantly reduced. Some lasers can even be used to weld the edges of tissue together and this in itself provides less need for suturing.\[[@ref14][@ref15][@ref16]\] The reduction in postoperative swelling appears to be related to sealing of lymphatic vessels.\[[@ref1]\] The interaction of laser energy with the pigmented portion of bacteria found in oral cavity contributes to reduction of bacterial count at the surgical site.\[[@ref17][@ref18][@ref19][@ref20][@ref21][@ref22]\] Another advantage of laser use in practise is the psychological effect on patient. It instills a greater confidence in the mind of the patient for the doctor who is seen as using the most latest and sophisticated equipment for treatment.\[[@ref23]\]

C[ARBONDIOXIDE]{.smallcaps} L[ASER (CO~2~)]{.smallcaps} {#sec1-2}
=======================================================

The CO~2~ laser is a gas-active medium laser that incorporates a sealed tube containing a gaseous mixture with CO~2~ molecules pumped via electrical discharge current. The light energy, whose wavelength is 10,600 nm, is placed at the end of the mid-infra-red invisible non-ionizing portion of the spectrum, and it is delivered through a hollow tube-like waveguide. The CO~2~ laser\'s ability to provide the required power in continuous and gated modes using focused or nonfocused hand-pieces gives this instrument the versatility and precision required for soft tissue surgical procedures.

The wavelength is well absorbed by water, second only to erbium family. It can easily cut and coagulate soft tissue and in addition has a shallow depth of penetration into soft tissue, which gives it an edge in treating mucosal lesions.

This wavelength has the highest absorption in hydroxyapatite of any dental laser, about 1000 times greater than erbium. Therefore, tooth structure adjacent to soft tissue surgical site must be shielded from the incident laser beam. The continuous wave emission and the technology of delivery system limit hard-tissue applications because carbonization and crazing of tooth structure can occur due to the long pulse duration and low-peak powers.\[[@ref24]\]

S[OFT TISSUE SURGERY USING CO~2~]{.smallcaps} L[ASER]{.smallcaps} {#sec1-3}
=================================================================

Frenectomy {#sec2-1}
----------

[Figure 1](#F1){ref-type="fig"} shows the preoperative view of a frenum that was placing excessive tension on the marginal gingival between the two maxillary central incisors. The treatment was planned to remove the frenum pull. The area was anesthetized with 2% lignocaine and adrenaline in the ratio of 1:80,000 The frenum was excised with CO~2~ laser set at 5W-focused mode \[[Figure 2](#F2){ref-type="fig"}\]. [Figure 3](#F3){ref-type="fig"} shows the immediate postoperative view. Note the char layer (biologic bandage) over the surgical site. [Figure 4](#F4){ref-type="fig"} shows the healing at 4 weeks.

![Preoperative view: High maxillary frenum](NJMS-6-84-g001){#F1}

![Frenum excised with laser](NJMS-6-84-g002){#F2}

![Immediate postoperative view](NJMS-6-84-g003){#F3}

![Healing at 4 weeks](NJMS-6-84-g004){#F4}

Excisional biopsy {#sec2-2}
-----------------

A laser may be used as a light scalpel to make relatively deep, thin cuts similar to that made with a scalpel. The technique requires the use of laser in a focused mode. Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"} show the buccal and occlusal views of a lesion that was planned for excisional biopsy using the laser. The lesion is first outlined using an intermittent, pulsed mode with a rate of 10 to 20 pulses per se cond to allow for superficial mark on the surface of the target. Once this is done, the laser is set to 5 w continuous mode power and the dots are joined to create the desired incision \[[Figure 7](#F7){ref-type="fig"}\]. When the appropriate depth has been reached, excision is performed by grasping the tissue with a forceps, slightly pulling it and horizontally undermining the tissue similar to that done by the blade. At this stage, care should be taken to prevent inadvertent damage to adjacent and posterior tissues by the laser when it passes through the specimen. Because bleeding and scarring are minimal, sutures are generally not required. The wound is left to granulate \[[Figure 8](#F8){ref-type="fig"}\].

![Buccal view of the lesion](NJMS-6-84-g005){#F5}

![Occlusal view of the lesion](NJMS-6-84-g006){#F6}

![Laserization of the site](NJMS-6-84-g007){#F7}

![Immediate postoperative view](NJMS-6-84-g008){#F8}

Figures [9](#F9){ref-type="fig"} to [12](#F12){ref-type="fig"} show a similar case of epulis excision using the CO~2~ laser.

![Pre-operative view of epulis](NJMS-6-84-g009){#F9}

![Laser treatment in progress](NJMS-6-84-g010){#F10}

![Immediate postoperative view](NJMS-6-84-g011){#F11}

![Healing site at 2 weeks](NJMS-6-84-g012){#F12}

Laser depigmentation {#sec2-3}
--------------------

[Figure 13](#F13){ref-type="fig"} shows the intraoral view of the mouth of a male patient who was unhappy with the appearance of "dark gums." On examination, it was found that patient had melanin pigmentation in buccal gingival of lower anterior teeth and between the upper central incisors. The area planned for depigmentation was anesthetized with 2% lignocaine with adrenaline in the ratio of 1:100,000. The CO~2~ laser set at 4 W continuous in a defocused mode was used. In this manner, it is possible to separate the epithelium from underlying connective tissue by creating a blister. Because the melanocytes are found in the basement membrane of epithelium, they will be permanently eliminated with the tissue that is removed. [Figure 14](#F14){ref-type="fig"} shows the view immediately after laserization. Note the char layer. After 2 weeks, the site has healed completely, and shows the normal gingival color \[[Figure 15](#F15){ref-type="fig"}\].

![Preoperative melanin pigmentation of gums](NJMS-6-84-g013){#F13}

![Appearance immediately after laserization](NJMS-6-84-g014){#F14}

![Healing at 2 weeks](NJMS-6-84-g015){#F15}

Use of lasers in treating white lesions {#sec2-4}
---------------------------------------

The successful treatment of white lesions in the oral cavity purely depends on the etiology and histopathology of the lesion. While the treatment of certain white lesions as lichen planus and hyperkeratosis can be easily accomplished, other lesions such as candidiasis and erythema multiforme may be totally unresponsive. [Figure 16](#F16){ref-type="fig"} shows a hyperkeratotic lesion on the lateral margin of tongue. After anesthetizing the area, the laser energy is directed at the lesion in defocused mode and slowly moved in a circular mode. The power used was 2 W \[[Figure 17](#F17){ref-type="fig"}\]. The process caused blister formation that separates epithelium from the underlying connective tissue. The re-evaluation appointment at 7 days shows the complete healing of the site \[[Figure 18](#F18){ref-type="fig"}\].

![White lesion on the lateral border of tongue](NJMS-6-84-g016){#F16}

![Site immediately after laser treatment](NJMS-6-84-g017){#F17}

![Healing at 1 week](NJMS-6-84-g018){#F18}
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